News | Susan G. Komen®️

All News

RSS

News Releases

Peoria Community Unites at 2026 Susan G. Komen® MORE THAN PINK Walk

April 14, 2026

Orlando Community Unites at 2026 Susan G. Komen® MORE THAN PINK Walk

April 14, 2026

The Greater St. Louis Community Unites at 2026 Susan G. Komen® MORE THAN PINK Walk

April 10, 2026

Columbus Community Unites at 2026 Susan G. Komen® Race for the Cure

April 10, 2026

Chicago Community Unites at 2026 Susan G. Komen® Race for the Cure

April 10, 2026

Minnesota Community Unites at 2026 Susan G. Komen® Race for the Cure

April 10, 2026

Triangle Community Unites at 30th Anniversary of the Susan G. Komen® Race for the Cure

April 8, 2026

Susan G. Komen® Urges Congress to Support Critical Breast Cancer Research and Safety Net Programs in FY27 Budget

April 6, 2026 Press Releases

1 2 3 … 43

Recent Podcasts

There is a lot of conversation right now about funding for cancer research and possible cuts to research projects that will improve our understanding and treatment of breast cancer. I’m pleased to be joined today by two researchers who are sharing their perspectives on the inextricable link between grant funding and sustained research. Dr. Benjamin Schrank is an Assistant Professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center, and Dr. Donald McDonnell is the Glaxo-Wellcome Distinguished Professor of Molecular Cancer Biology at Duke University School of Medicine. Dr. McDonnell is a well-established researcher whose work focuses on developing new drugs to treat metastatic breast cancer. Dr. Schrank is early in his research career and focused on harnessing the body’s immune system to improve response to treatments for metastatic breast cancer. Both recently received research grants from Susan G. Komen to support their innovative work that will help improve breast cancer care and patient outcomes.

Tomorrow’s Breakthroughs Depend on Today’s Research InvestmentsJune 29, 2026
Welcome to the Komen Health Equity Revolution series on Real Pink — where patients, advocates, researchers and community partners come together to talk honestly about what's standing in the way of breast health equity, and what we're doing to change it. June is Pride Month — a time to celebrate identity, community and the courage it takes to live authentically. Today's conversation sits right at the heart of that. Because advocating for yourself, knowing your body and refusing to be dismissed, that's not just a health message. That's a love letter to who you are. Our guest today is Shelby Smith. She was 30 years old when she noticed something felt off. No family history of breast cancer. Young, healthy, going about her life as a wife and mom to a 7-year-old daughter. But she trusted herself — and that decision changed everything. Shelby faced a 12-centimeter tumor, a bilateral mastectomy, 16 rounds of chemo and 15 rounds of radiation. She did her own research, built her own notebook, asked her own questions — and came out the other side with a message she wants every young woman to hear: Know your normal. And when something doesn't feel right, advocate for yourself.

Showing Up for YourselfJune 22, 2026
A breast cancer diagnosis may feel like it changes your entire life in an instant, but it doesn’t get to define who you are or make all your choices for you. On today's episode of Real Pink, we're joined by Amanda Sangemino, a remarkable young woman whose diagnosis came at an age when cancer was likely the last thing on her mind. What began with a concern that was initially dismissed ultimately led her to trust her instincts, advocate for herself, and make a series of personal decisions about her treatment and future. Throughout the process, she was determined not to let fear and cancer make every decision for her. Today, she’ll talk about the choices that she made about fertility, surgical options and maintaining an active lifestyle and why trusting yourself can be one of the most powerful tools you have.

Cancer Doesn’t Get the Final SayJune 15, 2026